{ "data": { "id": "org_ifpma", "slug": "ifpma", "name": "IFPMA", "short_name": "IFPMA", "type": "association", "tier": 2, "homepage": "https://www.ifpma.org", "country_code": "CH", "reliability_note": null, "url": "https://statorigin.org/sources/ifpma", "documents": [ { "title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "doc_type": "press_release", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok", "statistic_count": 7 } ], "statistics": [ { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF0", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0", "indicator": { "slug": "medicines-in-clinical-development", "name": "Medicines in clinical development", "definition": "Total number of medicines actively undergoing clinical development." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 12900, "value_text": "12,900", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0", "bibtex": "@misc{ifpma2025medicinesbjmgf0,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGEZ", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEZ", "indicator": { "slug": "novel-active-substance-launches", "name": "Novel active substance launches", "definition": "Total number of novel active substances launched." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2004-01-01", "end": "2023-12-31", "type": "year" }, "value": 942, "value_text": "942", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "Between 2004-2023, 942 novel active substances launched globally.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2023). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEZ", "bibtex": "@misc{ifpma2023novelbjmgez,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEZ},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF2", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF2", "indicator": { "slug": "pharmaceutical-r-d-gdp-contribution", "name": "Pharmaceutical R&D GDP contribution", "definition": "Gross domestic product contributed directly by pharmaceutical research and development activities." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 227, "value_text": "USD 227 billion", "unit": "USD", "currency": "USD", "scale": "billion", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "In 2022, the pharmaceutical sector’s R&D activities alone contributed USD 227 billion GDP globally, 30% of its direct contribution to the world economy.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2022). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF2", "bibtex": "@misc{ifpma2022pharmaceuticalbjmgf2,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF2},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF4", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF4", "indicator": { "slug": "pharmaceutical-r-d-employment", "name": "Pharmaceutical R&D employment", "definition": "Number of people employed directly in pharmaceutical research and development activities." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 1, "value_text": "1 million", "unit": "count", "currency": null, "scale": "million", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "Of the 7.8 million people directly employed by the pharmaceutical industry, over 1 million involved in R&D activities, fostering high-skilled employment and economic growth.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2022). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF4", "bibtex": "@misc{ifpma2022pharmaceuticalbjmgf4,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF4},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF3", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF3", "indicator": { "slug": "pharmaceutical-industry-direct-employment", "name": "Pharmaceutical industry direct employment", "definition": "Total number of people directly employed by the pharmaceutical industry." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 7.8, "value_text": "7.8 million", "unit": "count", "currency": null, "scale": "million", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "Of the 7.8 million people directly employed by the pharmaceutical industry, over 1 million involved in R&D activities, fostering high-skilled employment and economic growth.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2022). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF3", "bibtex": "@misc{ifpma2022pharmaceuticalbjmgf3,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF3},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_NZNKFES3X800FM9VC6A03C4RNW", "url": "https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW", "indicator": { "slug": "r-d-share-of-pharmaceutical-direct-economic-contribution", "name": "R&D share of pharmaceutical direct economic contribution", "definition": "Percentage of the pharmaceutical sector's direct gross economic contribution accounted for by research and development activities." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 30, "value_text": "30%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "In 2022, the pharmaceutical sector’s R&D activities alone contributed USD 227 billion GDP globally, 30% of its direct contribution to the world economy.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2022). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW", "bibtex": "@misc{ifpma2022share3c4rnw,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF1", "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1", "indicator": { "slug": "share-of-clinical-development-medicines-dedicated-to-non-communicable-diseases", "name": "Share of clinical development medicines dedicated to non-communicable diseases", "definition": "Proportion of medicines in clinical development that target non-communicable diseases." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 75, "value_text": "three-quarters", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IFPMA", "org_short_name": "IFPMA", "org_url": "https://www.ifpma.org", "org_tier": 2, "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/", "document_type": "press_release", "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines", "quote": "And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1", "bibtex": "@misc{ifpma2025sharebjmgf1,\n author = {{IFPMA}},\n title = {Enabling innovation: The R\\&D ecosystem for medicines and vaccines},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1},\n note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" } ] }, "meta": { "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.", "license": "https://creativecommons.org/licenses/by/4.0/", "docs": "https://statorigin.org/docs/api", "total": 7, "note": "Statistics are capped at 100 per request. Use /statistics?source_org=ifpma with a cursor to page through everything." } }